174 related articles for article (PubMed ID: 28751781)
1. Lower mean platelet volume predicts poor prognosis in renal cell carcinoma.
Yun ZY; Zhang X; Liu YS; Liu T; Liu ZP; Wang RT; Yu KJ
Sci Rep; 2017 Jul; 7(1):6700. PubMed ID: 28751781
[TBL] [Abstract][Full Text] [Related]
2. Association of decreased mean platelet volume with renal cell carcinoma.
Yun ZY; Zhang X; Liu ZP; Liu T; Wang RT; Chen H
Int J Clin Oncol; 2017 Dec; 22(6):1076-1080. PubMed ID: 28664301
[TBL] [Abstract][Full Text] [Related]
3. Elevated mean platelet volume predicts poor prognosis in colorectal cancer.
Li N; Yu Z; Zhang X; Liu T; Sun YX; Wang RT; Yu KJ
Sci Rep; 2017 Aug; 7(1):10261. PubMed ID: 28860547
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract][Full Text] [Related]
5. Decreased mean platelet volume predicts poor prognosis in invasive bladder cancer.
Wang X; Cui MM; Xu Y; Liu L; Niu Y; Liu T; Liu ZP; Wang RT; Yu KJ
Oncotarget; 2017 Sep; 8(40):68115-68122. PubMed ID: 28978101
[TBL] [Abstract][Full Text] [Related]
6. Increased preoperative levels of plasma fibrinogen and D dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics.
Erdem S; Amasyali AS; Aytac O; Onem K; Issever H; Sanli O
Urol Oncol; 2014 Oct; 32(7):1031-40. PubMed ID: 25027687
[TBL] [Abstract][Full Text] [Related]
7. Mean platelet volume is a prognostic factor in patients with acute kidney injury requiring continuous renal replacement therapy.
Han JS; Park KS; Lee MJ; Kim CH; Koo HM; Doh FM; Kim EJ; Han JH; Park JT; Han SH; Yoo TH; Kang SW; Oh HJ
J Crit Care; 2014 Dec; 29(6):1016-21. PubMed ID: 25138689
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of preoperative inflammatory response biomarkers in patients with sarcomatoid renal cell carcinoma and the establishment of a nomogram.
Gu L; Ma X; Li H; Chen L; Xie Y; Zhao C; Luo G; Zhang X
Sci Rep; 2016 Mar; 6():23846. PubMed ID: 27035802
[TBL] [Abstract][Full Text] [Related]
9. Reduced mean platelet volume is associated with poor prognosis in esophageal cancer.
Shen W; Cui MM; Wang X; Wang RT
Cancer Biomark; 2018; 22(3):559-563. PubMed ID: 29843218
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer.
Gao L; Zhang H; Zhang B; Zhang L; Wang C
Oncotarget; 2017 Feb; 8(9):15632-15641. PubMed ID: 28152504
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the combination of preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) in patients with renal cell carcinoma after nephrectomy.
Peng D; Zhang CJ; Tang Q; Zhang L; Yang KW; Yu XT; Gong Y; Li XS; He ZS; Zhou LQ
BMC Urol; 2018 Mar; 18(1):20. PubMed ID: 29544476
[TBL] [Abstract][Full Text] [Related]
12. Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients.
Zhang F; Chen Z; Wang P; Hu X; Gao Y; He J
Tumour Biol; 2016 Jul; 37(7):9323-31. PubMed ID: 26779631
[TBL] [Abstract][Full Text] [Related]
13. P2X7 receptor predicts postoperative cancer-specific survival of patients with clear-cell renal cell carcinoma.
Liu Z; Liu Y; Xu L; An H; Chang Y; Yang Y; Zhang W; Xu J
Cancer Sci; 2015 Sep; 106(9):1224-31. PubMed ID: 26179886
[TBL] [Abstract][Full Text] [Related]
14. Blood Platelet Volume Represents a Novel Prognostic Factor in Patients with Nonmetastatic Renal Cell Carcinoma and Improves the Predictive Ability of Established Prognostic Scores.
Seles M; Posch F; Pichler GP; Gary T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
J Urol; 2017 Dec; 198(6):1247-1252. PubMed ID: 28716649
[TBL] [Abstract][Full Text] [Related]
15. A novel prognostic model for patients with sarcomatoid renal cell carcinoma.
Zhang BY; Thompson RH; Lohse CM; Leibovich BC; Boorjian SA; Cheville JC; Costello BA
BJU Int; 2015 Mar; 115(3):405-11. PubMed ID: 24730416
[TBL] [Abstract][Full Text] [Related]
16. The independent association of mean platelet volume with overall survival in multiple myeloma.
Zhuang Q; Xiang L; Xu H; Fang F; Xing C; Liang B; Yu K; Feng J
Oncotarget; 2016 Sep; 7(38):62640-62646. PubMed ID: 27566590
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients.
Karakiewicz PI; Hutterer GC; Trinh QD; Jeldres C; Perrotte P; Gallina A; Tostain J; Patard JJ
Cancer; 2007 Sep; 110(6):1241-7. PubMed ID: 17639589
[TBL] [Abstract][Full Text] [Related]
18. Preoperative mean platelet volume predicts survival in breast cancer patients with type 2 diabetes.
Li N; Lv XH; Wang X; Wang RT; Huang YX
Breast Cancer; 2019 Nov; 26(6):712-718. PubMed ID: 31087273
[TBL] [Abstract][Full Text] [Related]
19. Low Preoperative Mean Platelet Volume/Platelet Count Ratio Indicates Worse Prognosis in Non-Metastatic Renal Cell Carcinoma.
Lin YC; Jan HC; Ou HY; Ou CH; Hu CY
J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441972
[TBL] [Abstract][Full Text] [Related]
20. Integrated staging systems for conventional renal cell carcinoma: a comparison of two prognostic models.
Martella O; Galatioto GP; Necozione S; Pomante R; Vicentini C
Arch Ital Urol Androl; 2011 Sep; 83(3):121-7. PubMed ID: 22184835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
